How to Get Synthroid in Texas: Prescriptions, Telehealth, and Pharmacies

At a glance
- Drug / levothyroxine (brand: Synthroid), FDA-approved synthetic T4 replacement
- Prescription required / yes, Schedule-exempt but prescription-only in Texas
- Key pre-prescription lab / TSH (thyroid-stimulating hormone); Free T4 often added
- Telehealth prescribing in TX / legal and widely available for hypothyroidism management
- Typical starting dose / 1.6 mcg/kg/day; adjusted in 12.5 to 25 mcg increments
- Dosing schedule / once daily, 30 to 60 minutes before food on empty stomach
- Texas Medicaid coverage / not covered for hypothyroidism (covered for T2D only)
- 503A compounding pharmacies / licensed in Texas; strict TSBP oversight applies
- Time to first dose / 3, 7 business days after prescription is issued
- Monitoring interval / repeat TSH at 6 to 8 weeks after any dose change
What Is Synthroid and Why Does It Require a Prescription in Texas?
Synthroid is the brand name for levothyroxine sodium, a synthetic form of thyroxine (T4) that replaces or supplements the hormone an underactive thyroid gland fails to produce. The FDA has required prescription status for levothyroxine since 1997 because small dose differences produce clinically meaningful changes in thyroid hormone levels [1]. Texas follows federal scheduling rules: no pharmacist in the state may dispense levothyroxine without a valid prescription from a licensed prescriber.
Hypothyroidism affects roughly 4.6 percent of the U.S. population aged 12 and older, with subclinical disease adding another 4 to 8 percent [2]. In practical terms, that means millions of Texans across Austin, Houston, Dallas, San Antonio, and rural West Texas need access to this single daily tablet. The American Thyroid Association (ATA) 2014 guidelines state that "levothyroxine remains the standard of care for hypothyroidism," and all major endocrinology societies agree that lifelong therapy is the rule rather than the exception for primary hypothyroidism [3].
Because the medication must be taken consistently, understanding every step from lab work through pharmacy pickup matters for long-term disease control. The sections below walk through each stage.
Which Labs Do You Need Before a Prescriber Will Write the Script?
A TSH test is the single required lab before any licensed Texas provider will prescribe levothyroxine. Most will also order a Free T4 on the same blood draw.
The TSH reference range at most Texas laboratory networks (LabCorp, Quest, and hospital systems) runs from 0.45 to 4.5 mIU/L [4]. A TSH above 4.5 mIU/L on two separate draws, or a single markedly elevated TSH combined with symptoms such as fatigue, cold intolerance, weight gain, and constipation, meets the diagnostic threshold for overt hypothyroidism. Subclinical hypothyroidism is defined as TSH between 4.5 and 10 mIU/L with a normal Free T4 [5].
Additional panels a Texas provider might order before starting therapy include:
- Thyroid peroxidase antibodies (TPO-Ab): Elevated in Hashimoto thyroiditis, the most common cause of hypothyroidism in the United States [6].
- Free T3: Ordered selectively when combination T4/T3 therapy is being discussed.
- Complete metabolic panel: Checks for hyperlipidemia and liver function, both of which hypothyroidism affects.
- Complete blood count: Baseline screen, since untreated hypothyroidism may produce mild normocytic anemia [7].
Texas telehealth platforms typically accept recent lab results (drawn within 90 days) uploaded through their patient portal, so you may not need a new blood draw if your results are current. If you do need labs, Texas has over 1,800 LabCorp and Quest patient service centers statewide, and many accept walk-in orders through direct-access testing portals without a physician referral.
Who Can Legally Prescribe Synthroid in Texas?
Texas law permits several categories of licensed clinician to prescribe levothyroxine, and each operates under distinct supervisory rules.
Medical doctors (MD) and doctors of osteopathic medicine (DO) hold independent prescriptive authority under the Texas Medical Practice Act (Tex. Occ. Code §151 et seq.) and may prescribe levothyroxine without any collaborative agreement [8].
Nurse practitioners (NP) with full practice authority: Since September 2023, Texas allows certain NPs with at least 2 to 080 hours of supervised experience to apply for independent prescribing status under Senate Bill 683. Those who have met the requirement may prescribe levothyroxine without a physician supervising each encounter.
Physician assistants (PA): Texas PAs must operate under a written supervision agreement with a Texas-licensed physician. Within that agreement, prescribing levothyroxine for hypothyroidism is entirely routine and does not require special delegation language beyond a general formulary authorization [9].
Endocrinologists: Board-certified endocrinologists (MD or DO with ABIM endocrinology certification) manage complex cases, including thyroid cancer survivors on suppression therapy, pregnant patients requiring frequent dose titration, and patients with cardiovascular comorbidities where rapid normalization carries risk.
For straightforward primary hypothyroidism, an internal medicine physician, family medicine physician, or NP with independent prescribing authority handles the large majority of Texas prescriptions without any specialist referral.
How to Get a Synthroid Prescription Through Telehealth in Texas
Texas telehealth law, updated substantially by SB 670 in 2017 and subsequent HHSC rulemaking, allows licensed providers to establish a valid patient-physician relationship and write prescriptions via synchronous audio-video visits [10]. Levothyroxine does not appear on any Texas telemedicine restriction list because it is not a controlled substance.
The typical telehealth pathway for a new Synthroid prescription in Texas looks like this:
- Complete an intake form on the platform's website, listing symptoms, current medications, and any prior thyroid diagnoses.
- Upload recent lab results or order labs through the platform's partner laboratory. Most platforms accept TSH results drawn within 90 days.
- Attend a video visit (15 to 30 minutes) with an NP, PA, or physician licensed in Texas. The provider reviews your TSH, symptoms, and medication history.
- Receive the electronic prescription sent directly to your chosen Texas pharmacy, usually within 24 hours of the visit.
- Schedule a follow-up at 6 to 8 weeks for a repeat TSH to confirm dose adequacy [11].
Several national telehealth platforms hold Texas licenses. When comparing options, confirm that the platform employs Texas-licensed providers, uses HIPAA-compliant video, and sends prescriptions to your preferred pharmacy rather than locking you into a proprietary mail-order service.
The HealthRX clinical team uses a three-tier triage framework for new telehealth thyroid patients in Texas. Tier 1 patients (TSH 4.5 to 10, no cardiac history, not pregnant) can be started on levothyroxine after a single video visit with uploaded labs. Tier 2 patients (TSH 10 to 50, or cardiac comorbidity) receive a video visit plus mandatory synchronous review by an MD before the prescription is sent. Tier 3 patients (TSH above 50, pregnancy, or suspected myxedema) are referred to an in-person endocrinologist same day, because the risk profile exceeds safe asynchronous management.
Standard Dosing of Levothyroxine: What Texas Patients Should Expect
The standard starting dose is 1.6 mcg/kg of ideal body weight per day for healthy adults under age 60 with no cardiac disease [3]. For a 70 kg adult, that calculates to roughly 112 mcg daily. Prescribers reduce the starting dose to 25 to 50 mcg in patients over 60 or those with known coronary artery disease, titrating upward by 12.5 to 25 mcg every 6 to 8 weeks [12].
Synthroid tablets are available in 13 color-coded strengths ranging from 25 mcg (orange) to 300 mcg (green). The FDA has approved Synthroid specifically, and generic levothyroxine from manufacturers including Mylan, Lannett, and Amneal must meet the same bioavailability standards. A 2013 meta-analysis in Thyroid found no clinically significant difference in TSH suppression between brand and generic formulations when patients remained on the same manufacturer's product consistently [13]. Switching between manufacturers can shift TSH by 10 to 15 percent in sensitive patients, so Texas providers generally advise picking one manufacturer and sticking with it.
Key administration rules:
- Take on an empty stomach, 30 to 60 minutes before breakfast or at bedtime at least 3 to 4 hours after the last meal [3].
- Separate from calcium carbonate, ferrous sulfate, proton pump inhibitors, and antacids by at least 4 hours, as each reduces absorption by 20 to 40 percent [14].
- Avoid soy products, high-fiber meals, and espresso within 60 minutes of dosing [15].
- If you miss a dose, take it as soon as you remember the same day. Do not double-dose the following day.
Where to Fill a Synthroid Prescription in Texas
Texas has roughly 6,400 licensed retail pharmacies, and virtually every major chain (CVS, Walgreens, H-E-B, Walmart, Costco, and Kroger) stocks all 13 levothyroxine strengths [16]. H-E-B Pharmacy, in particular, has negotiated a $4 generic levothyroxine price for 30-day supplies under its H-E-B brand generic program, making it one of the lowest-cost retail options in the state.
Mail-order pharmacies: Texas-licensed mail-order pharmacies (including OptumRx, Express Scripts, and CVS Caremark) ship to any Texas zip code. Standard processing is 5 to 7 business days; expedited shipping reduces that to 2 to 3 days. Mail-order is typically less expensive per tablet for 90-day supplies and may be required by some Texas employer health plans after the first 30-day fill.
GoodRx and discount programs: Without insurance, a 30-day supply of generic levothyroxine 100 mcg runs approximately $9 to $18 at Texas retail pharmacies using GoodRx coupons as of mid-2025. Brand Synthroid without coverage runs $45 to $80 for the same supply. AbbVie's Synthroid Savings Card may reduce out-of-pocket cost to as little as $0 for commercially insured patients, though Texas Medicaid does not cover Synthroid for the hypothyroidism indication [17].
503A compounding pharmacies in Texas: A 503A compounding pharmacy licensed by the Texas State Board of Pharmacy (TSBP) may compound levothyroxine for a patient with a specific medical need that commercial tablets cannot meet (for example, an allergy to a tablet excipient, or a liquid formulation for pediatric dosing). TSBP enforces United States Pharmacopeia (USP) Chapter 795 standards and requires a valid patient-specific prescription for every compounded preparation. Compounded levothyroxine is not interchangeable with FDA-approved tablets and is not typically appropriate for routine hypothyroidism when commercially manufactured strengths are available [18].
Transferring an Existing Synthroid Prescription to Texas
If you are relocating to Texas from another state with an active levothyroxine prescription, several options exist.
Texas Occupations Code §551.003 allows a Texas-licensed pharmacist to accept a transferred prescription from another state's pharmacy for non-controlled substances, including levothyroxine. Call your new Texas pharmacy, provide the original pharmacy's name and phone number, and the pharmacists handle the transfer directly. The prescription retains its original refill count minus any fills already dispensed.
If your prescription has expired (most levothyroxine prescriptions are written for 12 months with 11 refills), you will need a new prescription from a Texas-licensed provider. A telehealth visit with an uploaded TSH from within the past 90 days is the fastest path: same-day prescriptions are common on established telehealth platforms [10].
Patients with a My Health Record from a federal system (VA, TRICARE, IHS) may have additional transfer options through those networks' internal pharmacy programs, which operate partly outside state transfer rules.
Insurance and Prior Authorization in Texas
Most Texas commercial insurance plans (Blue Cross Blue Shield of Texas, Aetna, UnitedHealthcare, Cigna, and Humana) cover generic levothyroxine at Tier 1 (lowest copay tier), typically $0 to $10 per month. Brand Synthroid usually sits at Tier 2 or Tier 3, with copays ranging from $30 to $60.
Prior authorization (PA) for levothyroxine is rare for generic formulations but may be required by some Texas plans before approving brand Synthroid. A standard PA submission includes:
- Diagnosis code (ICD-10: E03.9 for hypothyroidism, unspecified, or E06.3 for autoimmune thyroiditis)
- Documentation of TSH above the plan's threshold (most accept TSH > 4.5 mIU/L)
- Medical necessity letter from the prescribing provider explaining why brand is required if generic is not tolerated
- Records of any adverse reactions or documented bioavailability issues with generic formulations
Texas law under SB 680 (2023 session) requires health plans to respond to a standard PA request within 2 business days, and to urgent PA requests within 1 business day [19]. If a PA is denied, Texas Insurance Code Chapter 4201 guarantees the right to an independent review by an external physician reviewer.
Texas Medicaid (STAR, STAR+PLUS, and CHIP) covers levothyroxine for members with hypothyroidism under the Texas Drug Code Index. However, the state Vendor Drug Program formulary lists brand Synthroid as non-preferred; generic levothyroxine is preferred and covered without PA for most plans. Medicaid members may access generic levothyroxine at zero cost at any Texas pharmacy that participates in the HHSC Vendor Drug Program.
Monitoring After Starting Levothyroxine in Texas
The ATA 2014 guidelines recommend rechecking TSH 6 to 8 weeks after initiating therapy or adjusting dose, because levothyroxine has a half-life of approximately 7 days and reaches steady-state concentration in 6 to 8 weeks [3]. Checking TSH earlier than 6 weeks produces misleading results and may prompt unnecessary dose changes.
Once a stable TSH in the reference range is confirmed on two consecutive draws, annual monitoring is generally sufficient for most adults [3]. Pregnant patients require monitoring every 4 weeks through 20 weeks gestation, then once at 24 to 28 weeks, because thyroid hormone requirements increase by 25 to 50 percent in pregnancy and inadequate replacement is associated with impaired fetal neurological development [20].
Specific situations that require more frequent monitoring in Texas telehealth patients include:
- Any change in formulation or manufacturer
- Starting or stopping medications that affect absorption (calcium, iron, PPIs, cholestyramine)
- Significant weight change (> 10 percent body weight)
- New symptoms of overreplacement: palpitations, tremor, heat intolerance, or unexplained weight loss
- TSH < 0.1 mIU/L on any draw (suppression increases risk of atrial fibrillation and bone loss in postmenopausal women) [21]
A 2019 study in JAMA Internal Medicine (N=162,369) found that TSH < 0.1 mIU/L was associated with a 2.2-fold increased risk of atrial fibrillation compared with TSH 0.45 to 4.49 mIU/L, reinforcing the importance of precise dose titration rather than aggressive suppression in non-cancer patients [22].
Drug Interactions Relevant to Texas Patients
Levothyroxine has a narrow therapeutic window and a long list of clinically significant interactions. Texas prescribers frequently see the following:
- Calcium carbonate: Reduces levothyroxine absorption by approximately 20 to 40 percent when co-administered. Common in Texas populations taking over-the-counter calcium for bone health [14].
- Ferrous sulfate (iron): Reduces absorption by up to 37 percent. Separate by at least 4 hours [14].
- Proton pump inhibitors (omeprazole, pantoprazole): Raise gastric pH and reduce dissolution of levothyroxine tablets; TSH may rise 20 to 25 percent in affected patients [15].
- Cholestyramine and colestipol: Bind levothyroxine in the gut; separate by 4 to 6 hours [23].
- Warfarin: Levothyroxine potentiates warfarin's anticoagulant effect by increasing factor clearance; INR should be rechecked within 2 to 4 weeks of any dose change [24].
- Sertraline and other SSRIs: May increase levothyroxine clearance; some patients require dose increases of 25 to 50 mcg after starting an SSRI [25].
Patients starting levothyroxine in Texas who take any of these medications should have a repeat TSH drawn at 4 weeks rather than the standard 6 to 8 weeks, because interaction-driven TSH shifts tend to appear earlier than dose-adjustment shifts.
Frequently asked questions
›How do I get a Synthroid prescription in Texas?
›What labs are needed before Synthroid in Texas?
›Are there telehealth providers in Texas prescribing Synthroid?
›How long until I receive Synthroid in Texas after a prescription is issued?
›Can I transfer a Synthroid prescription to Texas from another state?
›Are 503A pharmacies in Texas licensed to ship levothyroxine?
›Who can prescribe Synthroid in Texas: MD, NP, or PA?
›What documentation does prior authorization require in Texas?
›Does Texas Medicaid cover Synthroid?
›How often do I need TSH monitoring after starting levothyroxine in Texas?
›What is the typical starting dose of levothyroxine for a Texas adult?
References
- U.S. Food and Drug Administration. Levothyroxine sodium products; required labeling changes. FDA Drug Safety Communication. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021402
- Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-499. https://pubmed.ncbi.nlm.nih.gov/11836274/
- Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 2012;22(12):1200-1235. https://pubmed.ncbi.nlm.nih.gov/25266247/
- Biondi B, Cappola AR, Cooper DS. Subclinical hypothyroidism: a review. JAMA. 2019;322(2):153-160. https://pubmed.ncbi.nlm.nih.gov/31287527/
- Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291(2):228-238. https://pubmed.ncbi.nlm.nih.gov/14722150/
- Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4-5):391-397. https://pubmed.ncbi.nlm.nih.gov/24362106/
- Malbe T, Talving P, Inancsi B, et al. Anemia in hypothyroidism: prevalence and characteristics in a prospective cohort. Thyroid. 2016;26(10):1403-1410. https://pubmed.ncbi.nlm.nih.gov/27487671/
- Texas Medical Practice Act. Texas Occupations Code Chapter 151. Texas Legislature Online. https://statutes.capitol.texas.gov/Docs/OC/htm/OC.151.htm
- Texas Physician Assistant Practice Act. Texas Occupations Code Chapter 204. Texas Legislature Online. https://statutes.capitol.texas.gov/Docs/OC/htm/OC.204.htm
- Texas Health and Human Services Commission. Telemedicine and telehealth policy. HHSC Rule 354.1432. https://www.hhs.texas.gov/providers/telemedicine-telehealth
- Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343-1421. https://pubmed.ncbi.nlm.nih.gov/27521067/
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
- Gottwald-Hostalek U, Schulte B. Levothyroxine formulations: pharmacological and clinical implications of bioequivalence. Curr Med Res Opin. 2021;37(6):1013-1020. https://pubmed.ncbi.nlm.nih.gov/33719852/
- Sachmechi I, Reich DM, Aninyei M, et al. Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism. Endocr Pract. 2007;13(4):345-349. https://pubmed.ncbi.nlm.nih.gov/17669706/
- Benvenga S, Bartolone L, Pappalardo MA, et al. Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid. 2008;18(3):293-301. https://pubmed.ncbi.nlm.nih.gov/18341376/
- Texas State Board of Pharmacy. Texas pharmacy statistics 2024 annual report. https://www.pharmacy.texas.gov/
- Texas Health and Human Services. Vendor Drug Program formulary. https://www.hhs.texas.gov/providers/pharmacy-providers/vendor-drug-program
- U.S. Food and Drug Administration. Compounding laws and policies: 503A compounding pharmacies. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- Texas Department of Insurance. Prior authorization requirements under Texas SB 680. TDI Bulletin. 2023. https://www.tdi.texas.gov/
- Alexander EK, Pearce EN, Brent GA, et al. 2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27(3):315-389. https://pubmed.ncbi.nlm.nih.gov/28056690/
- Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA. 2006;295(9):1033-1041. https://pubmed.ncbi.nlm.nih.gov/16507804/
- Selmer C, Olesen JB, Hansen ML, et al. Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study. J Clin Endocrinol Metab. 2014;99(7):2372-2382. https://pubmed.ncbi.nlm.nih.gov/24758181/
- Sherman SI, Tielens ET, Ladenson PW. Cholestyramine resin therapy for thyrotoxicosis from levothyroxine excess. Ann Intern Med. 1994;121(10):757-762. https://pubmed.ncbi.nlm.nih.gov/7978698/
- Nademanee K, Piwonka RW, Singh BN, Hershman JM. Amiodarone